You have read all your free articles, to continue reading subscribe to read the rest of this content.
Oncopeptides has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA), for OPD5 - a second drug candidate based on the Peptide Drug Conjugate platform (PDC). Oncopeptides plans to initiate clinical development of OPD5 with an open-label phase 1, dAlready a subscriber Login You…
The two companies receive a Eurostars R&D grant to deliver AId, a novel artificial intelligence-based tool for drug discovery. In a strategic partnership between Desupervised and Red Glead Discovery the companies have joined forces to create AI-based solutions enabling companies to reduce cosAlready a subscriber Login You have read all…
SAGA Diagnostics has entered into an assay development agreement with AstraZeneca. SAGA Diagnostics will in the course of this agreement develop SAGAsafe dPCR assays towards undisclosed methylated targets for analyses of tissue samples and liquid biopsies. "We have chosen to partner with SAGA Already a subscriber Login You have read…
The Chinese National Medical Products Administration (NMPA) has approved the oral androgen receptor inhibitor (ARi) darolutamide in combination with docetaxel for the treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC). Darolutamide is already approved in China for theAlready a subscriber Login You have read all your free articles, to…
